A Gene Transfer Therapy Study to Evaluate the Safety and Efficacy of Delandistrogene Moxeparvovec (SRP-9001) in Participants With Duchenne Muscular Dystrophy (DMD)
Clinical trial NCT05096221 · COMPLETED
Trial details
- NCT number
- NCT05096221
- Sponsor
- Sarepta Therapeutics, Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-10-27
- Primary completion
- 2023-10-04
- Enrollment
- 126
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.